What question did this study set out to answer?

To evaluate the effectiveness of gastropexy in reducing recurrence rates post-paraesophageal hernia repair.

March 18, 2026TrialsOpen Access

Can gastropexy reduce the recurrence rate after paraesophageal hernia repair? A study protocol for a double blind, randomized, multicenter clinical trial

View Full Paper

Ask AI

Bookmark

Authors

Double-blind trial investigates gastropexy's impact on recurrence rates in paraesophageal hernia repair, suggesting potential benefits.

To evaluate the effectiveness of gastropexy in reducing recurrence rates post-paraesophageal hernia repair.
Eligibility assessment of patients scheduled for paraesophageal hernia repair.
Patients are randomized into control (standard repair) and intervention (gastropexy added) groups.
Primary outcome measured is CT-verified recurrence at 1 year, with secondary outcomes focused on quality of life and symptoms.
Anticipated results will include the rate of radiological recurrence at 1 and 3 years.
Patient-reported outcomes related to quality of life and symptoms will also be assessed.
Data on postoperative complications will be collected for analysis.

Dackhammar et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark